NCT01075282 A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2) Status COMPLETED Phase PHASE3
NCT01070329 A Study in Depression and Associated Painful Physical Symptoms Status COMPLETED Phase PHASE4
NCT01066845 Post Marketing Observational Study in Patients With Pulmonary Arterial Hypertension Status COMPLETED Phase N/A
NCT01060059 Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes Status COMPLETED Phase N/A
NCT01059643 A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT01057589 A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT01056549 Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans Status COMPLETED Phase NA
NCT01042158 A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis Status COMPLETED Phase PHASE4
NCT01035073 Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort Syndrome Status COMPLETED Phase PHASE4
NCT01029886 Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01029795 A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus Status TERMINATED Phase PHASE2
NCT01028352 Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated Pain Status COMPLETED Phase NA